Austrian vaccine developer Hookipa Biotech raises $27.5m series B funding supported by Boehringer Ingelheim Venture Fund and Takeda Ventures, to develop its lead vaccine for immunization against cytomegalovirus and to industrialize its Vaxwave technology for tackling infectious diseases and cancer.

Sheffield University spin-out Phase Focus announces changes at the top.

Auditor KPMG launches KPMG Capital, a technology fund dedicated to bringing data and analytics solutions to its clients.

A robotic arm that boosts human strength has won the 2013 James Dyson award as the team behind it looks towards commercialisation.

Coventry University, along with spin-out Microcab, due to demonstrate zero-emission hydrogen fuel car.

Robert Bosch Venture Capital and Siemens Technology Accelerator join $4m investment in Scottish maker of low power infrared sensors.